PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Zoutendijk, Roeand [1 ]
Hansen, Bettina E. [1 ]
van Vuuren, Anneke J. [1 ]
Boucher, Charles A. [1 ]
Janssen, Harry L. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
381
引用
收藏
页码：509A / 509A
页数：1
相关论文
共 50 条
  • [41] Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
    Broquetas, Teresa
    Carrion, Jose A.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2022, 14 : 87 - 100
  • [42] IMPROVED HBsAg LOSS RATE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PROLONGED PEGINTERFERON α-2a COMBINED WITH NUCLEOS(T)IDE ANALOGUE
    Wang, S. Q.
    Xu, K. J.
    Wu, J. Z.
    Luongo, T. T.
    Yang, R. G.
    Geng, X. X.
    Huang, R. G.
    Lin, J. M.
    Yang, X. X.
    Jiang, N.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S317 - S317
  • [43] Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
    Ibragimov, E. K.
    Abdurakhmanov, D. T.
    Rozina, T. P.
    Nikulkina, E. N.
    Tanaschuk, E. L.
    Odintsov, A., V
    Panevkina, S., V
    Moiseev, S., V
    TERAPEVTICHESKII ARKHIV, 2019, 91 (02) : 40 - 47
  • [44] Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
    Kim, Hyo Jin
    Cho, Ju-Yeon
    Kim, Yu Jin
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Koh, Kwang Cheol
    Paik, Seung Woon.
    Yoo, Byung Chul
    Lee, Joon Hyeok
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (01): : 32 - 41
  • [45] EARLY ON-TREATMENT HBV RNA AND HBCRAG PROFILES PREDICT FAVOURABLE HBsAg SUPPRESSION OR SEROCLEARANCE UPON LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B INFECTION
    Mak, Lung-Yi
    Wong, Danny
    Kuchta, Alison
    Hilfiker, Martina
    Hamilton, Aaron
    Seto, Wai Kay Walter
    Yuen, Man-Fung
    HEPATOLOGY, 2021, 74 : 433A - 434A
  • [46] Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
    zu Siederdissen, Christoph Hoener
    Rinker, Franziska
    Maasoumy, Benjamin
    Wiegand, Steffen B.
    Filmann, Natalie
    Falk, Christine S.
    Deterding, Katja
    Port, Kerstin
    Mix, Carola
    Manns, Michael P.
    Herrmann, Eva
    Wedemeyer, Heiner
    Kraft, Anke R. M.
    Cornberg, Markus
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (10): : 1492 - 1497
  • [47] HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogues therapy
    Michele Barone
    Andrea Iannone
    Alfredo Di Leo
    World Journal of Gastroenterology, 2014, 20 (26) : 8722 - 8725
  • [48] Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ridruejo, Ezequiel
    Silva, Marcelo O.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 357 - 360
  • [49] HBsAg Is Still Detected By Ultrasensitive HBsAg Test in Patients Post-Liver Transplantation on Long-Term Monotherapy with Nucleos(t)Ide Analogue after Hbig Withdrawal
    Carey, Lvana
    Bruce, Matthew
    Moigboi, Christiana
    Heneghan, Michael A.
    Considine, Aisling
    Dusheiko, Geoffrey M.
    Agarwal, Kosh
    HEPATOLOGY, 2018, 68 : 715A - 716A
  • [50] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
    He, D.
    Guo, S.
    Zhu, P.
    Tao, S.
    Li, M.
    Huang, H.
    Wang, J.
    Wang, Y.
    Ding, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
12345